Christopher John Boyle

US Patent:

8128690, Mar 6, 2012

Filed:

Jul 15, 2010

Appl. No.:

12/837443

Inventors:

Christopher T. Boyle - Flushing NY, US

Assignee:

Advanced Bio Prosthetic Surfaces, Ltd. - Dallas TX

International Classification:

A61F 2/82

US Classification:

623 142, 623 127

Abstract:

The present invention consists of an implantable structural element for in vivo delivery of bioactive active agents to a situs in a body. The implantable structural element may be configured as an implantable prosthesis, such as an endoluminal stent, cardiac valve, osteal implant or the like, which serves a dual function of being prosthetic and a carrier for a bioactive agent. Alternatively, the implantable structural element may simply be an implantable article that serves the single function of acting as a time-release carrier for the bioactive agent.

US Patent:

8221493, Jul 17, 2012

Filed:

Feb 5, 2008

Appl. No.:

12/026509

Inventors:

Christopher T. Boyle - Flushing NY, US
Steven R. Bailey - San Antonio TX, US

Assignee:

ABPS Venture One, Ltd. - Dallas TX

International Classification:

A61F 2/06
A61F 2/24

US Classification:

623 124

Abstract:

This invention relates to prosthetic cardiac and venous valves and a single catheter device and minimally invasive techniques for percutaneous and transluminal valvuloplasty and prosthetic valve implantation.

US Patent:

20050186241, Aug 25, 2005

Filed:

Sep 9, 2004

Appl. No.:

10/936884

Inventors:

Christopher Boyle - Flushing NY, US
Steven Bailey - San Antonio TX, US
Denes Marton - San Antonio TX, US
Christopher Banas - San Antonio TX, US

International Classification:

A61F002/06

US Classification:

424423000, 623001340

Abstract:

The present invention consists of an implantable structural element for in vivo controlled delivery of bioactive active agents to a situs in a body. The implantable structural element may be configured as an implantable prosthesis, such as an endoluminal stent, cardiac valve, osteal implant or the like, which serves a dual function of being prosthetic and a carrier for a bioactive agent. Control over elution of the bioactive agents occurs through a plurality of cantilever-like cover members which prevent drug elution until an endogenous or exogenous stimulus causes the cover members to open and permit drug elution.

US Patent:

20100217373, Aug 26, 2010

Filed:

Jan 12, 2010

Appl. No.:

12/686350

Inventors:

Christopher T. Boyle - Flushing NY, US
Denes Marton - San Antonio TX, US
Christopher E. Banas - Breckenridge CO, US

Assignee:

Advanced Bio Prosthetic Surfaces, Ltd., a wholly owned subsidiary of Palmaz Scientific, Inc. - Dallas TX

International Classification:

A61F 2/84
A61F 2/82

US Classification:

623 111, 623 115, 623 123

Abstract:

The present invention relates to an implantable endoluminal graft comprised of a microporous thin-film covering having a plurality of openings and a structural support element underlying and physically attached to the microporous thin-film covering, the microporous thin-film covering having shape memory properties.

US Patent:

20120221098, Aug 30, 2012

Filed:

Mar 5, 2012

Appl. No.:

13/412407

Inventors:

Christopher T. Boyle - Flushing NY, US

Assignee:

Advanced Bio Prosthetic Surfaces, Ltd., a wholly owned subsidiary of Palmaz Scientific, Inc. - Dallas TX

International Classification:

A61F 2/82
A61F 2/90

US Classification:

623 117, 623 115, 600 36

Abstract:

The present invention consists of an implantable structural element for in vivo delivery of bioactive active agents to a situs in a body. The implantable structural element may be configured as an implantable prosthesis, such as an endoluminal stent, cardiac valve, osteal implant or the like, which serves a dual function of being prosthetic and a carrier for a bioactive agent. Alternatively, the implantable structural element may simply be an implantable article that serves the single function of acting as a time-release carrier for the bioactive agent.

US Patent:

20120310158, Dec 6, 2012

Filed:

Aug 16, 2012

Appl. No.:

13/587821

Inventors:

Christopher T. Boyle - Flushing NY, US
Steven R. Bailey - San Antonio TX, US
Christopher E. Banas - Breckenridge CO, US
Julio C. Palmaz - Napa CA, US

Assignee:

Advanced Bio Prosthetic Surfaces, Ltd., a wholly owned subsidiary of Palmaz Scientific, Inc. - Dallas TX

International Classification:

A61M 25/10
B22D 25/02

US Classification:

60410101, 164131

Abstract:

A metal balloon catheter having a main tubular body, a metal balloon proximate a distal end of the main tubular body, a central annulus extending along an entire longitudinal aspect of the catheter for accommodating a guidewire therethrough and an inflation annulus adjacent the central annulus which extends along the longitudinal axis of the main tubular body and terminates in fluid flow communication with an inflation chamber of the metal balloon. The metal balloon catheter may be either unitary integral metal catheter in which the main tubular body and the balloon are fabricated of metal, or it may consist of a polymeric main tubular body and a metal balloon.

US Patent:

20130166018, Jun 27, 2013

Filed:

Aug 20, 2012

Appl. No.:

13/589683

Inventors:

Christopher T. Boyle - Flushing NY, US
Steven R. Bailey - San Antonio TX, US
Denes Marton - San Antonio TX, US
Christopher E. Banas - Breckenridge CO, US

Assignee:

Advanced Bio Prosthetic Surfaces, Ltd., a wholly owned subsidiary of Palmaz Scientific, Inc. - Dallas TX

International Classification:

A61F 2/82

US Classification:

623 143, 623 142

Abstract:

The implantable structural element for in vivo controlled delivery of bioactive active agents to a situs in a body. The implantable structural element may be configured as an implantable prosthesis, such as an endoluminal stent, cardiac valve, osteal implant or the like, which serves a dual function of being prosthetic and a carrier for a bioactive agent. Control over elution of the bioactive agents occurs through a plurality of cantilever-like cover members which prevent drug elution until an endogenous or exogenous stimulus causes the cover members to open and permit drug elution.

US Patent:

20130274687, Oct 17, 2013

Filed:

Mar 11, 2013

Appl. No.:

13/794215

Inventors:

Christopher T. Boyle - Flushing NY, US

International Classification:

A61M 5/14

US Classification:

60428804

Abstract:

The present invention consists of an implantable structural element for in vivo delivery of bioactive active agents to a situs in a body. The implantable structural element may be configured as an implantable prosthesis, such as an endoluminal stent, cardiac valve, osteal implant or the like, which serves a dual function of being prosthetic and a carrier for a bioactive agent. Alternatively, the implantable structural element may simply be an implantable article that serves the single function of acting as a time-release carrier for the bioactive agent.